The science is in question.
A 30,000 page IND that took months and months to get through with caveats by the FDA.
2 years of PAR doing non-clinical studies in the background and a failed dosing study results in very very lukewarm reception by the FDA.
TGA provisional approval gate should have been by now - so why the radio silence. The timeframe should be 30 days from submission at this checkpoint - a submission they delayed for four years.
and if you think that’s bad - a fund management firm that has no experience in pharma is now hired as their business development consultant to get them out of this mess.
- Forums
- ASX - By Stock
- PAR
- Where we at?
Where we at?, page-666
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $101.4M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 29.0¢ | $40.16K | 137.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 66491 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 33118 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 56491 | 0.290 |
4 | 62455 | 0.285 |
2 | 50360 | 0.280 |
3 | 44999 | 0.275 |
5 | 42556 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 33118 | 1 |
0.305 | 50000 | 1 |
0.310 | 68600 | 2 |
0.315 | 38304 | 5 |
0.320 | 70187 | 4 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online